A novel biomarker, active whole skeletal total lesion glycolysis (WS-TLG), as a quantitative method to measure bone metastatic activity in breast cancer patients

OBJECTIVE: There is no good response evaluation method for skeletal metastasis. We aimed to develop a novel quantitative method to evaluate the response of skeletal metastasis, especially lytic lesions, for treatment. METHODS: A method to measure active bone metastatic burden quantitatively using F-...

Descripción completa

Detalles Bibliográficos
Autores principales: Koizumi, Mitsuru, Motegi, Kazuki, Umeda, Takuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609583/
https://www.ncbi.nlm.nih.gov/pubmed/30982124
http://dx.doi.org/10.1007/s12149-019-01359-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609583/
https://www.ncbi.nlm.nih.gov/pubmed/30982124
http://dx.doi.org/10.1007/s12149-019-01359-4

Ejemplares similares